{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:59:18Z","timestamp":1787021958454,"version":"build-2736575974"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,26]],"date-time":"2015-08-26T00:00:00Z","timestamp":1440547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0135427","type":"journal-article","created":{"date-parts":[[2015,8,26]],"date-time":"2015-08-26T14:01:33Z","timestamp":1440597693000},"page":"e0135427","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["1,25-Dihydroxyvitamin D to PTH(1\u201384) Ratios Strongly Predict Cardiovascular Death in Heart Failure"],"prefix":"10.1371","volume":"10","author":[{"given":"Damien","family":"Gruson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ferracin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie A.","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Zierold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Blocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Bonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel F.","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,26]]},"reference":[{"issue":"42","key":"ref1","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1093\/eurheartj\/ehu299","article-title":"Cardiovascular disease in Europe 2014: epidemiological update","volume":"35","author":"M Nichols","year":"2014","journal-title":"Eur Heart J"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ejhf.43","article-title":"Heart failure highlights in 2012\u20132013","volume":"16","author":"LC Liu","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"20","key":"ref3","first-page":"IV14","article-title":"Congestive heart failure: fifty years of progress","volume":"102","author":"E Braunwald","year":"2000","journal-title":"Circulation"},{"issue":"13","key":"ref4","first-page":"10","article-title":"2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","author":"CW Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"3A","key":"ref5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.amjcard.2007.11.017","article-title":"Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms","volume":"101","author":"JL Januzzi Jr.","year":"2008","journal-title":". Am J Cardiol"},{"key":"ref6","article-title":"Cardiovascular disease in Europe 2014: epidemiological update","author":"M Nichols","year":"2014","journal-title":"Eur Heart J"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1751-7133.2008.08312.x","article-title":"Cost-effectiveness of B-type natriuretic peptide testing","volume":"14","author":"C Mueller","year":"2008","journal-title":"Congest Heart Fail"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"e75174","DOI":"10.1371\/journal.pone.0075174","article-title":"Depletion of proBNP1-108 in patients with heart failure prevents cross-reactivity with natriuretic peptides","volume":"8","author":"F Roubille","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"e58287","DOI":"10.1371\/journal.pone.0058287","article-title":"Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials","volume":"8","author":"G Savarese","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"A Maisel","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/eurjhf\/hfp035","article-title":"Old and new biomarkers of heart failure","volume":"11","author":"M Emdin","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"ref12","article-title":"Natriuretic peptides in cardiovascular diseases: current use and perspectives","author":"M Volpe","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/07853890.2010.538080","article-title":"Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction","volume":"43","author":"RA de Boer","year":"2011","journal-title":"Ann Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cca.2014.03.029","article-title":"PTH: Potential role in management of heart failure","volume":"433","author":"D Gruson","year":"2014","journal-title":"Clin Chim Acta"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"e95402","DOI":"10.1371\/journal.pone.0095402","article-title":"Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease","volume":"9","author":"J Tunon","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/eurjhf\/hfr016","article-title":"Parathyroid hormone and vitamin D\u2014markers for cardiovascular and all cause mortality in heart failure","volume":"13","author":"LL Schierbeck","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"TJ Wang","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvs092","article-title":"Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease","volume":"94","author":"A Tomaschitz","year":"2012","journal-title":"Cardiovasc Res"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/ndt\/gfs050","article-title":"FGF23 and PTH\u2014double agents at the heart of CKD","volume":"27","author":"J Silver","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"22","key":"ref20","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.jacc.2014.03.026","article-title":"Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease","volume":"63","author":"JA Udell","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrneph.2014.49","article-title":"Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease","volume":"10","author":"JJ Scialla","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"ref22","article-title":"Experience with the first fully automated chemiluminescence immunoassay for the quantification of 1alpha, 25-dihydroxy-vitamin D","author":"HJ van","year":"2014","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/07853890701689645","article-title":"Calcium and phosphate homeostasis: concerted interplay of new regulators","volume":"40","author":"KY Renkema","year":"2008","journal-title":"Ann Med"},{"key":"ref24","article-title":"Associations of 25(OH) and 1,25(OH) Vitamin D with Long-Term Outcomes in Stable Renal Transplant Recipients","author":"CA Keyzer","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1373\/clinchem.2008.120006","article-title":"Circulating calcitriol concentrations and total mortality","volume":"55","author":"A Zittermann","year":"2009","journal-title":"Clin Chem"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1210\/jc.2009-1773","article-title":"Update in vitamin D","volume":"95","author":"JS Adams","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejheart.2008.01.013","article-title":"Poor outcome in end-stage heart failure patients with low circulating calcitriol levels","volume":"10","author":"A Zittermann","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/eurjhf\/hfr175","article-title":"Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome","volume":"14","author":"I Gotsman","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/CIRCHEARTFAILURE.114.001272","article-title":"Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease","volume":"7","author":"SG Wannamethee","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/jc.2013-2963","article-title":"Plasma fibroblast growth factor 23, parathyroid hormone, 25-hydroxyvitamin D3, and risk of heart failure: a prospective, case-cohort study","volume":"99","author":"R di Giuseppe","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/ndt\/gfm517","article-title":"Adolphe Quetelet (1796\u20131874)\u2014the average man and indices of obesity","volume":"23","author":"G Eknoyan","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"4\u20135","key":"ref32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clinbiochem.2012.12.002","article-title":"Comparison between intact and bioactive parathyroid hormone assays in patients with severe heart failure","volume":"46","author":"D Gruson","year":"2013","journal-title":"Clin Biochem"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.amjcard.2011.08.039","article-title":"Relation of serum parathyroid hormone level to severity of heart failure","volume":"109","author":"H Altay","year":"2012","journal-title":"Am J Cardiol"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00000441-200601000-00009","article-title":"Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure","volume":"331","author":"RN Khouzam","year":"2006","journal-title":"Am J Med Sci"},{"issue":"11","key":"ref35","first-page":"987","article-title":"Increased circulating concentrations of bioactive PTH 1\u201384 in patients with heart failure","volume":"35","author":"D Gruson","year":"2012","journal-title":"J Endocrinol Invest"},{"issue":"22","key":"ref36","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ehj.2003.09.010","article-title":"Parathyroid hormone and left ventricular hypertrophy","volume":"24","author":"FN Saleh","year":"2003","journal-title":"Eur Heart J"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","article-title":"Hyperparathyroidism and the calcium paradox of aldosteronism","volume":"111","author":"VS Chhokar","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10557-012-6378-0","article-title":"Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism","volume":"27","author":"MR Rutledge","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"H286","DOI":"10.1152\/ajpheart.00535.2005","article-title":"Calcium paradox of aldosteronism and the role of the parathyroid glands","volume":"290","author":"A Vidal","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"ref40","doi-asserted-by":"crossref","first-page":"e107681","DOI":"10.1371\/journal.pone.0107681","article-title":"FGF23 deficiency leads to mixed hearing loss and middle ear malformation in mice","volume":"9","author":"AC Lysaght","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrendo.2009.196","article-title":"The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis","volume":"5","author":"MS Razzaque","year":"2009","journal-title":". Nat Rev Endocrinol"},{"key":"ref42","article-title":"The potential roles of FGF23 and Klotho in the prognosis of renal and cardiovascular diseases","author":"J Bernheim","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study","volume":"152","author":"BD Parker","year":"2010","journal-title":"Ann Intern Med"},{"issue":"19","key":"ref44","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"OM Gutierrez","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.peptides.2012.08.003","article-title":"C-terminal FGF23 is a strong predictor of survival in systolic heart failure","volume":"37","author":"D Gruson","year":"2012","journal-title":"Peptides"},{"issue":"39","key":"ref46","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","author":"S Liu","year":"2003","journal-title":"J Biol Chem"},{"issue":"7","key":"ref47","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/01.CIR.0000024113.26985.CC","article-title":"Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro","volume":"106","author":"G Li","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"ref48","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s10571-010-9564-2","article-title":"Inositol 1,4,5-trisphosphate receptor in chromaffin secretory granules and its relation to chromogranins","volume":"30","author":"SH Yoo","year":"2010","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EC-14-0027","article-title":"Biological function and clinical relevance of chromogranin A and derived peptides","volume":"3","author":"MA D'amico","year":"2014","journal-title":"Endocr Connect"},{"issue":"24","key":"ref50","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.2174\/092986712802430009","article-title":"Chromogranin-A: a multifaceted cardiovascular role in health and disease","volume":"19","author":"T Angelone","year":"2012","journal-title":"Curr Med Chem"},{"key":"ref51","article-title":"Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantation","author":"C Wu","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.diabres.2014.01.031","article-title":"The impact of 1,25-dihydroxyvitamin D3 on the expression of connective tissue growth factor and transforming growth factor-beta1 in the myocardium of rats with diabetes","volume":"104","author":"L Wang","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"23","key":"ref53","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1093\/eurheartj\/ehr459","article-title":"Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress","volume":"33","author":"J Dong","year":"2012","journal-title":"Eur Heart J"},{"issue":"5","key":"ref54","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000013384","article-title":". Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis","volume":"18","author":"S Lemmila","year":"1998","journal-title":"Am J Nephrol"},{"issue":"2","key":"ref55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/MAJ.0b013e318134f013","article-title":"Cinacalcet and the prevention of secondary hyperparathyroidism in rats with aldosteronism","volume":"335","author":"Y Selektor","year":"2008","journal-title":"Am J Med Sci"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jacc.2008.03.039","article-title":"Fracture risk in men with congestive heart failure risk reduction with spironolactone","volume":"52","author":"LD Carbone","year":"2008","journal-title":"J Am Coll Cardiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0135427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T15:18:43Z","timestamp":1718032723000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0135427"}},"subtitle":[],"editor":[{"given":"Claudio","family":"Passino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,26]]},"references-count":56,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0135427","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,26]]}}}